Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions

## Example Bundle: Alicia Gravitate's IPS - Local

id: Ovl-gravitate-Alicia
Composition status: final
Composition Type: Patient summary Document
Subject:
identifier: alicia-1-local
Name: Alicia Gravitate
active: true
gender: female
Birth Date: 1998-10-05

### Sections

#### Problem List

Condition: Depressive disorder (disorder) (35489007)
clinicalStatus: active
Condition: Human immunodeficiency virus infection (86406008)
clinicalStatus: active
asserter: Dr. Walter Waltz
onsetDateTime: 2018
Condition: Trigeminal neuralgia (disorder) (31681005)
clinicalStatus: active
asserter: Dr. Walter Waltz
onsetDateTime: 2018
Condition: Overweight (finding) (238131007)
clinicalStatus: active
asserter: Dr. Walter Waltz
onsetDateTime: 2018

#### Medication Summary

Medication: BIKTARVY Bictegravir/Emtricitabine/Tenofovir Alafenamide 1 t QD
status: active
Medication Detail:

- System https://spor.ema.europa.eu/pmswi Code: EU/1/18/1289/001 [Biktarvy 30 mg/120 mg/15 mg film-coated tablets]

- System https://www.who-umc.org/phpid Code: 0x073AF2E5B92AE19E8B67635AFFB3D9nq [Biktarvy 30 mg/120 mg/15 mg film-coated tablets]

- System http://snomed.info/sct Code: 774856007 [Product containing only bictegravir and emtricitabine and tenofovir (medicinal product)]

- System http://www.whocc.no/atc Code: J05AR20 [emtricitabine, tenofovir alafenamide and bictegravir]

Dose Form: Coated tablet
Ingredient: bictegravir (http://fdasis.nlm.nih.gov#8GB79LOJ07)
strength: 30 mg/1 Tablet
Ingredient: emtricitabine (http://fdasis.nlm.nih.gov#G70B4ETF4S)
strength: 120 mg/1 Tablet
Ingredient: tenofovir alafenamida (http://fdasis.nlm.nih.gov#EL9943AG5J)
strength: 15 mg/1 Tablet
Route: Oral use
Medication: CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES
status: active
Medication Detail:

- System https://spor.ema.europa.eu/pmswi Code: 68290 [CALCIO/VITAMINA D3 ROVI 1000 mg/880 UI COMPRIMIDOS EFERVESCENTES]

- System https://www.who-umc.org/phpid Code: 0xF79CABF272B6A7EEF104DDDA44E82716 [Calcium Vitamin D]

Dose Form: Effervescent tablet
Ingredient: Calcium carbonate (http://fdasis.nlm.nih.gov#H0G9379FGK)
strength: 1000 mg/1 Tablet
Ingredient: cholecalciferol (http://fdasis.nlm.nih.gov#1C6V77QF41)
strength: 880 {UI}/1 Tablet
Route: Oral use
Medication: Carbamazepine 1 t TID
status: active
Medication Detail:

- System https://spor.ema.europa.eu/pmswi Code: 39.955 [Tegretol (Carbamazepine) 200 mg tablets]

- System https://www.who-umc.org/phpid Code: 0x6e5dd079852edc5c3b8efce075c80a2e [Carbamazepine 200 mg tablets]

Dose Form: Tablet
Ingredient: CARBAMAZEPINE (http://fdasis.nlm.nih.gov#33CM23913M)
strength: 200 mg/1 Tablet
Route: Oral use
Medication: Orlistat 1 cp TID
status: active
Medication Detail:

- System https://spor.ema.europa.eu/pmswi Code: EU/1/98/071/004 [Xenical (Orlistat) 60 mg capsule]

- System https://www.who-umc.org/phpid Code: 0xc805ef896d1c2f5f17f84f34c909a9db [Xenical (Orlistat) 60 mg capsule]

Dose Form: Capsule, hard
Ingredient: ORLISTAT (http://fdasis.nlm.nih.gov#95M8R751W8)
strength: 60 mg/1 Tablet
Route: Oral use
Medication: St. John’s Wort 2 cp BID
status: active
Medication Detail:

- System https://spor.ema.europa.eu/pmswi Code: 79963 [HIPÉRICO ARKOPHARMA cápsulas duras]

- System https://www.who-umc.org/phpid Code: 0xbb82cd10ab2add752b2b9224931099j1 [St. John's Wort (HIPÉRICO ARKOPHARMA) hard tablet]

- System http://www.whocc.no/atc Code: A03FA02 [HYPERICUM PERFORATUM WHOLE]

Dose Form: Tablet
Ingredient: HYPERICUM PERFORATUM WHOLE (http://fdasis.nlm.nih.gov#XK4IUX8MNB)
strength: 175 mg/1 Tablet
Route: Oral use
Medication: Flucelvax
status: active
Medication Detail:

- System https://spor.ema.europa.eu/pmswi Code: EU/1/18/1326/001 [Flucelvax]

- System https://www.who-umc.org/phpid Code: 0xbb82cd10ab2add752b2b9224931000k2 [Flucelvax]

- System http://www.whocc.no/atc Code: A03ku92 [Flucelvax]

Dose Form: suspension for injection in pre-filled syringe
Ingredient: INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) WHOLE (http://fdasis.nlm.nih.gov#TU2UN5CG9C)
strength: 15 mcg/1 suspension for injection in pre-filled syringe
Route: Intramuscular use
Medication: Remsima 100 mg powder for concentrate for solution for infusion
status: active
Route: Intravenous use

#### Allergies and Intolerances

#### Pregnancy

#### Social History

#### Vital Signs